FindTrial
Sign In

Effectiveness of Matrix Therapeutic Model in Treating Patients with Stimulant-Drug Abuse

Effectiveness of Matrix Therapeutic Model in Treating Patients with Stimulant-Drug Abuse

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017061233946N3
Enrollment
40
Registered
2017-08-27
Start date
2015-04-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Abuse. Personal history of psychoactive substance abuse

Interventions

Matrix Therapeutic Model: 24 session based on Matrix Manual.
Behavior
Matrix Therapeutic Model: 24 session based on Matrix Manual

Sponsors

Vice chancelor for research Zanjan Univercity of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with Stimulant-Drug Abuse; aging 18-50 years old; junior high school third graders; no medicine consumption 1 month before the intervention. Exclusion criteria: psychotic disorder; suicide rick; aggressive behavior.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
ASI (Addiction Severity Index ). Timepoint: Pre intervention, 3.5 months after. Method of measurement: ASI test.;Anxiety. Timepoint: Pre intervention, 3.5 months after. Method of measurement: DASS-21.;Depression. Timepoint: Pre intervention, 3.5 months after. Method of measurement: DASS-21.;Stress. Timepoint: Pre intervention, 3.5 months after. Method of measurement: DASS-21.;Urinary test. Timepoint: Pre intervention, 3.5 months after. Method of measurement: Urinary kit.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohsen Dadashi

Zanjan University of Medical Sciences and Health Services

psy.mohsen@gmail.com+98 24 3378 9469

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026